G6PD and malaria: In total, 3.3% of patients had a variant G6PD genotype, which compares to an earlier study in North Sumatera showing a 5% prevalence of G6PD deficiency [5]; the slightly lower prevalence in vivax patients in the current study might relate to the protective effect of G6PD deficiency against malaria [16–18].